XML 26 R17.htm IDEA: XBRL DOCUMENT v3.21.2

STOCKHOLDERS EQUITY (Tables)

9 Months Ended

Jun. 30, 2021

Warrants recorded as equity exercised

		Three Months												Nine Months
Warrants		Warrants Exercised				Exercise Price				Proceeds				Warrants Exercised				Exercise Price				Proceeds
Series Z			-				-			$	-				79,200			$	13.75			$	1,089,000
Series ZZ			19,200			$	13.75				264,000				20,000			$	13.75				275,000
Series AA			-				-				-				100,000			$	13.75				1,375,000
Series CC			5,000			$	5.00				25,000				107,298			$	5.00				536,490
			24,200							$	289,000				306,498							$	3,275,490

		Three Months												Nine Months
Warrants		Warrants Exercised				Exercise Price				Proceeds				Warrants Exercised				Exercise Price				Proceeds
Series V			674,164			$	13.75			$	9,269,755				674,164			$	13.75			$	9,269,755
Series CC			-				-				-				123,820			$	5.00				619,100
Series FF			-				-				-				68,048			$	3.91				265,812
Series HH			-				-				-				6,300			$	3.13				19,687
Series JJ			-				-				-				9,450			$	3.13				29,531
Series LL			-				-				-				26,398			$	3.59				94,867
			674,164							$	9,269,755				908,180							$	10,298,752

Stock options, stock bonuses and compensation granted by the Company

Name of Plan		Total Shares Reserved Under Plans				Shares Reserved for Outstanding Options				Shares Issued				Remaining Options/Shares Under Plans
Incentive Stock Options Plans			138,400				76,829				N/A				213
Non-Qualified Stock Option Plans			11,787,200				11,001,880				N/A				404,826
Stock Bonus Plans			783,760				N/A				358,118				425,609
Stock Compensation Plans			634,000				N/A				150,695				464,895
Incentive Stock Bonus Plan			640,000				N/A				614,500				25,500

Stock option activity

		Nine Months Ended June 30,
		2021				2020
Options granted			2,603,500				2,561,200
Options exercised			126,954				94,199
Options forfeited			42,166				1,000
Options expired			9,374				1,180

		Three Months Ended June 30,
		2021				2020
Options granted			2,595,500				2,559,000
Options exercised			72,809				73,719
Options forfeited			-				16
Options expired			9,307				-

Stock-based compensation expense

		Nine months Ended June 30,
		2021				2020
Employees		$	10,090,410			$	6,690,331
Non-employees		$	955,900			$	623,146

		Three months Ended June 30,
		2021				2020
Employees		$	3,511,359			$	3,109,127
Non-employees		$	403,236			$	275,919

Derivative liabilities, warrants and other options

Warrant/Options		Issue Date		Shares Issuable upon Exercise of Warrants/ Options				Exercise Price				Expiration Date			Reference
Series N		8/18/2008			85,339			$	3.00			8/18/2022			2
Series UU		6/11/2018			93,603			$	2.80			6/30/2022			2
Series X		1/13/2016			120,000			$	9.25			7/13/2022			2
Series Y		2/15/2016			26,000			$	12.00			8/15/2022			2
Series BB		8/26/2016			16,000			$	13.75			8/22/2021			*
Series Z		5/23/2016			184,800			$	13.75			11/23/2021			*
Series CC		12/8/2016			41,345			$	5.00			12/8/2021			1
Series HH		2/23/2017			200			$	3.13			2/16/2022			*
Series AA		8/26/2016			100,000			$	13.75			2/22/2022			*
Series MM		6/22/2017			333,432			$	1.86			6/22/2022			2
Series NN		7/24/2017			217,838			$	2.52			7/24/2022			2
Series RR		10/30/2017			251,761			$	1.65			10/30/2022			2
Series SS		12/19/2017			220,800			$	2.09			12/18/2022			*
Series TT		2/5/2018			100,868			$	2.24			2/5/2023			2
Consultants		7/28/2017 – 11/18/2020			15,000			$	2.18 - $11.61			11/17/2022 - 7/27/2027			3

Schedule of fair value of warrant liabilites

		June 30, 2021				September 30, 2020
Series W warrants		$	-			$	73,570
Series Z warrants			429,996				1,207,902
Series ZZ warrants			-				75,044
Series AA warrants			263,818				1,082,212
Series BB warrants			16,696				65,173
Series CC warrants			206,978				1,259,712
Series HH warrants			1,216				2,000
Total warrant liabilities		$	918,704			$	3,765,613

Schedule of gain and (losses) on derivative liabilities

		2021				2020
Series V warrants		$	-			$	185,652
Series W warrants			73,570				(614,696	)
Series Z warrants			(113,094	)			(742,495	)
Series ZZ warrants			(98,692	)			(38,319	)
Series AA warrants			(306,606	)			(547,454	)
Series BB warrants			48,477				(44,620	)
Series CC warrants			(596,001	)			(1,245,627	)
Series FF warrants			-				(319,706	)
Series HH warrants			784				(35,024	)
Series JJ warrants			-				(64,992	)
Series LL warrants			-				(98,066	)
Net loss on warrant liabilities		$	(991,562	)		$	(3,565,347	)

		2021				2020
Series V warrants		$	-			$	107,191
Series W warrants			-				(247,327	)
Series Z warrants			583,404				(430,619	)
Series ZZ warrants			(87,162	)			(33,734	)
Series AA warrants			355,215				(220,831	)
Series BB warrants			64,678				(37,592	)
Series CC warrants			199,256				(419,350	)
Series HH warrants			1,228				(567	)
Net (gain) loss on warrant liabilities		$	1,116,619			$	(1,282,829	)

		Nine Months Ended								Three Months Ended
		June 30, 2021				June 30, 2020				June 30, 2021				June 30, 2020
Realized through the resale of shares		$	1,436,473			$	2,539,245			$	761,237			$	818,565
Fair value of shares upon issuance			-				1,769,500				-				1,769,500
Other non-operating gain (loss)		$	1,436,473			$	769,745			$	761,237			$	(950,935	)

Options and Warrants [Member]

Warrants recorded as equity exercised

		Three Months												Nine Months
Warrants		Warrants Exercised				Exercise Price				Proceeds				Warrants Exercised				Exercise Price				Proceeds
Series MM			147,929			$	1.86			$	275,148				464,201			$	1.86			$	863,414
Series NN			109,170			$	2.52				275,108				131,004			$	2.52				330,130
Series RR			95,799			$	1.65				158,068				165,888			$	1.65				273,715
Series SS			-				-				-				105,264			$	2.09				220,002
Series TT			60,214			$	2.24				134,879				270,696			$	2.24				606,359
			413,112							$	843,204				1,137,053							$	2,293,620

		Three Months												Nine Months
Warrants		Warrants Exercised				Exercise Price				Proceeds				Warrants Exercised				Exercise Price				Proceeds
Series NN			-				-			$	-				98,253			$	2.52			$	247,598
Series OO			10,000			$	2.52				25,200				50,000			$	2.52				126,000
Series SS			39,474			$	2.09				82,500				156,580			$	2.09				327,252
Series TT			10,000			$	2.24				22,400				188,125			$	2.24				421,400
Series UU			61,207			$	2.80				171,380				61,207			$	2.80				171,380
Series VV			55,000			$	1.75				96,250				82,500			$	1.75				144,375
			175,681							$	397,730				636,665							$	1,438,005

X

- References

No definition available.

+ Details

Name:	cvm_ExercisedWarrantsRecordedAsEquityTableTextBlock
Namespace Prefix:	cvm_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	cvm_ScheduleOfDerivativeLiabilitiesWarrantsAndOtherOptions
Namespace Prefix:	cvm_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	cvm_ScheduleOfFairValueOfWarrantLiabilitestabletextblock
Namespace Prefix:	cvm_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	cvm_ScheduleOfGainAndLossesOnDerivativeLiabilitiesTableTextBlock
Namespace Prefix:	cvm_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	cvm_ScheduleStockOptionsStockBonusesAndCompensationGrantedByCompany
Namespace Prefix:	cvm_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of an equity-based arrangement (such as stock or unit options and stock or unit awards) with an individual employee, which is generally an employment contract between the entity and a selected officer or key employee containing a promise by the employer to pay certain equity-based awards at future dates, sometimes including a period after retirement, upon compliance with stipulated requirements. This type of arrangement is distinguished from broader based employee benefit plans as it is usually tailored to the employee. Disclosure also typically includes the amount of related compensation expense recognized during the reporting period, the number of shares or units issued during the period under such arrangements, and the carrying amount as of the balance sheet date of the related liability.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 710
-SubTopic 10
-Section 30
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6409875&loc=d3e20015-108363

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 710
-SubTopic 10
-Section 55
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=6409961&loc=d3e20517-108367

+ Details

Name:	us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualShareBasedPaymentsTextBlock
Namespace Prefix:	us-gaap_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (e)
-URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(1)
-URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901

+ Details

Name:	us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Details

Name:	us-gaap_OptionIndexedToIssuersEquityEquityAxis=cvm_OptionsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type: